Human liver carcinoma cells (HuH-7), which are susceptible to EAV infection (Fig. 1A) (23) and produce high titers of infectious virus, were used based on their responsiveness to IFN-β treatment (Fig. 1B) (32). This evidence concerns the gene IFNB1 and hepatocellular carcinoma.